Zobrazeno 1 - 10
of 326
pro vyhledávání: '"Kyoung-Ah Kim"'
Autor:
Nam Hoon Kim, Juneyoung Lee, Suk Chon, Jae Myung Yu, In-Kyung Jeong, Soo Lim, Won Jun Kim, Keeho Song, Ho Chan Cho, Hea Min Yu, Kyoung-Ah Kim, Sang Soo Kim, Soon Hee Lee, Chong Hwa Kim, Soo Heon Kwak, Yong‐ho Lee, Choon Hee Chung, Sihoon Lee, Heung Yong Jin, Jae Hyuk Lee, Gwanpyo Koh, Sang-Yong Kim, Jaetaek Kim, Ju Hee Lee, Tae Nyun Kim, Hyun Jeong Jeon, Ji Hyun Lee, Jae-Han Jeon, Hye Jin Yoo, Hee Kyung Kim, Hyeong-Kyu Park, Il Seong Nam-Goong, Seongbin Hong, Chul Woo Ahn, Ji Hee Yu, Jong Heon Park, Keun-Gyu Park, Chan Ho Park, Kyong Hye Joung, Ohk-Hyun Ryu, Keun Yong Park, Eun-Gyoung Hong, Bong-Soo Cha, Kyu Chang Won, Yoon-Sok Chung, Sin Gon Kim
Publikováno v:
Endocrinology and Metabolism, Vol 39, Iss 5, Pp 722-731 (2024)
Background Atherogenic dyslipidemia, which is frequently associated with type 2 diabetes (T2D) and insulin resistance, contributes to the development of vascular complications. Statin therapy is the primary approach to dyslipidemia management in T2D,
Externí odkaz:
https://doaj.org/article/0dcfa97890d0434694d5229e34ac68b1
Autor:
Jin-Woo Park, Hyewon Chung, Jong-Min Kim, Na Young Kim, Sung Hee Hong, Kyoung-Ah Kim, Ji-Young Park
Publikováno v:
Drugs in R&D, Vol 24, Iss 2, Pp 179-186 (2024)
Abstract Background and Objective This study aimed to assess and compare the pharmacokinetics, safety, and tolerability of a fixed-dose combination product (FDCP) comprising four different drugs (two antihypertensive drugs, amlodipine and losartan, a
Externí odkaz:
https://doaj.org/article/84f6c55ae0d7488296fb2d473df47bd3
Publikováno v:
Diabetes & Metabolism Journal, Vol 47, Iss 4, Pp 523-534 (2023)
Background Diabetic kidney disease (DKD) is a risk factor for hospitalization for heart failure (HHF). DKD could be classified into four phenotypes by estimated glomerular filtration rate (eGFR, normal vs. low) and proteinuria (PU, negative vs. posit
Externí odkaz:
https://doaj.org/article/152157b7d69c401094d9c57bca90b00c
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-9 (2023)
Abstract Background Diabetes mellitus is a major risk factor for heart failure. A recent consensus statement recommended annual cardiac biomarker testing (e.g. natriuretic peptide or high-sensitivity cardiac troponin) for all patients with diabetes.
Externí odkaz:
https://doaj.org/article/3aadcca6e86f432ab8d550c8eeb38923
Publikováno v:
Diabetes & Metabolism Journal, Vol 46, Iss 4, Pp 567-577 (2022)
Background Although cardiovascular outcome trials using sodium-glucose cotransporter-2 inhibitors (SGLT-2i) showed a reduction in risk of 3-point major adverse cardiovascular events (MACE), they did not demonstrate beneficial effects on stroke risk.
Externí odkaz:
https://doaj.org/article/0893be71ea0f4ba880dc8a7ee30e72e2
Publikováno v:
Endocrinology and Metabolism, Vol 37, Iss 1, Pp 148-158 (2022)
Background Diabetic kidney disease (DKD) is associated with an elevated risk of fractures. However, little is known about the association between proteinuric or non-proteinuric DKD and the risk of hip fracture. Thus, we investigated the incidence of
Externí odkaz:
https://doaj.org/article/7fb651d392d24594a3b594e62567afa1
Publikováno v:
Journal of Obesity & Metabolic Syndrome, Vol 30, Iss 4, Pp 345-353 (2021)
Background : The increasing prevalence of type 2 diabetes mellitus (T2DM) has led to a significant health burden. Technological advancements have highlighted the benefits of digital therapeutics for chronic diseases. In this study, we aimed to invest
Externí odkaz:
https://doaj.org/article/01ed0040f6dc4fc6952bb53251cba904
Autor:
Eu Jeong Ku, Chaelin Lee, Jaeyoon Shim, Sihoon Lee, Kyoung-Ah Kim, Sang Wan Kim, Yumie Rhee, Hyo-Jeong Kim, Jung Soo Lim, Choon Hee Chung, Sung Wan Chun, Soon-Jib Yoo, Ohk-Hyun Ryu, Ho Chan Cho, A Ram Hong, Chang Ho Ahn, Jung Hee Kim, Man Ho Choi
Publikováno v:
Endocrinology and Metabolism, Vol 36, Iss 5, Pp 1131-1141 (2021)
Background Conventional diagnostic approaches for adrenal tumors require multi-step processes, including imaging studies and dynamic hormone tests. Therefore, this study aimed to discriminate adrenal tumors from a single blood sample based on the com
Externí odkaz:
https://doaj.org/article/e60005c6253447c284f8e197d933172b
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Sodium-glucose cotransporter 2 inhibitor (SGLT2i) should be considered for patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) having estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m2 and urine alb
Externí odkaz:
https://doaj.org/article/832b08f61d1c452bac66a2bb52c2ae9f
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 364 (2023)
Higher risk of major hemorrhage associated with concomitant use of dabigatran and simvastatin compared to other statins was previously reported with a suggestion of P-glycoprotein-mediated interaction. The aim of this study was to evaluate the effect
Externí odkaz:
https://doaj.org/article/b72aa4c874af46a7a1ff2c5edde39101